Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

NCHHSTP Newsroom
Your Connection to the Latest HIV/AIDS, Hepatitis, STD and TB News at CDC

HIV Prevention in the United States:

Expanding the Impact

Expanding the Impact
To Date
in HIV
of HIV

HIV Medications

Antiretroviral medications used to treat HIV can also be used to prevent it:

Preventing Mother-to-child Transmission (PMTCT)

Administering antiretroviral medications to HIV-infected pregnant women and their newborns significantly reduces the risk of HIV transmission to infants during pregnancy, labor and delivery, and breastfeeding.2, 3

Treatment as Prevention for People with HIV

Treating people with HIV lowers the amount of virus in their body and can dramatically reduce their risk of transmitting HIV to others, underscoring the importance of HIV testing and access to medical care and treatment. In fact, a landmark clinical trial in 2011 showed that people with HIV who began taking anti-HIV medications early (before their immune systems were significantly weakened) experienced a 96 percent reduction in their risk of transmitting HIV to their sexual partners.4

Post-exposure Prophylaxis (PEP)

When started promptly after exposure to HIV, antiretroviral medications can reduce the risk of infection.5, 6 For example, a nurse accidentally stuck with a needle that may have been in contact with HIV-infected blood can reduce the risk of infection by completing a four-week course of medications. Partially thanks to PEP, there have been no confirmed cases of occupational HIV transmission to health care workers in the United States since 1999. Non-occupational PEP can also reduce risk of infection if started promptly after exposure to HIV through sexual risk behavior or injection drug use.

Pre-exposure Prophylaxis (PrEP)

With PrEP, HIV-negative individuals take a daily dose of antiretroviral medication to lower their chances of acquiring HIV. When used consistently, PrEP has been shown to reduce the risk of HIV infection among adult men and women at very high risk for HIV infection through sex or injecting drug use. Studies have evaluated the use of the drug TDF, alone or in combination with FTC, and have shown that the level of protection is strongly related to the level of adherence to the daily regimen.7, 8, 9, 10

In time, PrEP may play an important role in HIV prevention, and work is ongoing to determine how to successfully implement PrEP programs in an efficient and cost-effective manner. Demonstration projects and open-label studies now underway will begin to address some of the critical real-world questions about how to most effectively use PrEP in combination with other proven prevention methods.

Media Inquiries:
HIV/AIDS, Hepatitis, STDs or TB
  • (404) 639-8895
    M-F 9am-5:30pm (ET)
  • Email

All Other Topics

Public Inquiries:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    TTY: (888) 232-6348

  • Contact CDC–INFO

The NCHHSTP Atlas is an interactive tool that provides CDC an effective way to disseminate HIV, Viral Hepatitis, STD and TB data, while allowing users to observe trends and patterns by creating detailed reports, maps, and other graphics. Find out more!

Prevention Through Health Care

May 19. HEPATITIS TESTING DAY.  Click here to learn more.

CDC 24/7 – Saving Lives. Protecting People. Saving Money Through Prevention. Learn More About How CDC Works For You The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #